본문 바로가기

High Glucose Causes Human Cardiac Progenitor Cell Dysfunction by Promoting Mitochondrial Fission: Role of a GLUT1 Blocker

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
Biomolecules & Therapeutics24 · pp.363 · 2016
피인용
Web of Science 12KCI 0
JCR IF
JCR 2015 2.127
ISSN
1976-9148

저자

  1. 최혜윤제1저자부산대학교 의과학과
  2. 박지혜부산대학교
  3. 장웅비부산대학교 의과학과
  4. 지승택부산대학교
  5. 정석윤부산대학교
  6. 김다연부산대학교
  7. 강송화부산대학교
  8. 김연주부산대학교 의과학과
  9. 윤지수부산대학교
  10. 김재호부산대학교
  11. 백상홍교신저자가톨릭대학교
  12. 권상모교신저자부산대학교

초록

Cardiovascular disease is the most common cause of death in diabetic patients. Hyperglycemia is the primary characteristic of diabetes and is associated with many complications. The role of hyperglycemia in the dysfunction of human cardiac progenitor cells that can regenerate damaged cardiac tissue has been investigated, but the exact mechanism underlying this association is not clear. Thus, we examined whether hyperglycemia could regulate mitochondrial dynamics and lead to cardiac progenitor cell dysfunction, and whether blocking glucose uptake could rescue this dysfunction. High glucose in cardiac progenitor cells results in reduced cell viability and decreased expression of cell cycle-related molecules, including CDK2 and cyclin E. A tube formation assay revealed that hyperglycemia led to a significant decrease in the tube-forming ability of cardiac progenitor cells. Fluorescent labeling of cardiac progenitor cell mitochondria revealed that hyperglycemia alters mitochondrial dynamics and increases expression of fission-related proteins, including Fis1 and Drp1. Moreover, we showed that specific blockage of GLUT1 improved cell viability, tube formation; and regulation of mitochondrial dynamics in cardiac progenitor cells. To our knowledge, this study is the first to demonstrate that high glucose leads to cardiac progenitor cell dysfunction through an increase in mitochondrial fission, and that a GLUT1 blocker can rescue cardiac progenitor cell dysfunction and downregulation of mitochondrial fission. Combined therapy with cardiac progenitor cells and a GLUT1 blocker may provide a novel strategy for cardiac progenitor cell therapy in cardiovascular disease patients with diabetes.

키워드

Cardiac progenitor cellHyperglycemiaFasentinMitochondrial dynamicsDiabetic cardiomyopathy

식별자

WoS UID
000379378600002
KCI
ART002115802